PARALLAXSEEPrimary editorial space
← All spacesForecasts about therapies, diagnostics, biotechnology and public health, written with explicit deadlines and a clear boundary between editorial research and professional medical advice. 07 active predictions, ordered by distance.
ParallaxSee Medicine & Health
Forecast 01 Target 2035Open prediction
Chinese clinical studies and Japanese tooth-growth research are opening different routes to dental regeneration. The clearest path toward useful treatment begins with rebuilding living tissue inside and around teeth that patients still have.
ParallaxSee Medicine & Health
Forecast 02 Target 2035Open prediction
Longevity research is moving toward treatments that preserve sight, mobility and independence. Academic studies and patents support a hopeful 2035 forecast for larger human trials showing benefits against age-related decline.
ParallaxSee Medicine & Health
Forecast 03 Target 2035Open prediction
A molecule that interrupts the signal for making sperm has reached human trials. Its promise extends beyond reproductive biology: couples could gain a new way to share the work of preventing pregnancy, with a prescription written in the man's name.
ParallaxSee Medicine & Health
Forecast 04 Target 2040Open prediction
The science points towards medical inhalers that deliver nutrients to selected patients. Their success will depend on reliable dosing, respiratory safety and a convincing advantage over existing treatment.
ParallaxSee Medicine & Health
Forecast 05 Target 2040Open prediction
A skin cell can already be reset, assigned to the germ line and taken through much of the journey towards an egg. Meiosis, imprinting and egg cytoplasm are the remaining engineering frontier.
ParallaxSee Medicine & Health
Forecast 06 Target 2035Open prediction
Gene-edited pigs, better rejection control and earlier immune-warning tests will keep at least one recipient alive and off dialysis for a full year by 2035.
ParallaxSee Medicine & Health
Forecast 07 Target 2045Open prediction
Photoreceptor replacement, flexible electronics and neural adaptation will return useful vision to people with retinal degeneration by 2045.
